RM
Therapeutic Areas
Endomimetics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Bionanomatrix™ Vascular Access Gel | Arteriovenous Fistula (AVF) Maturation for Dialysis | Pre-clinical |
| Bionanomatrix™ Coating for Cardiovascular Devices | Prevention of Thrombosis/Restenosis in Stents & Grafts | Pre-clinical |
| Bionanomatrix™ for Orthopedic Implants | Infection Prevention & Improved Healing | Pre-clinical |
| Bionanomatrix™ for Dental Applications (with BISCO) | Pulp Capping & Peri-implantitis | Pre-clinical |
| Bionanomatrix™ Coating for Neurovascular Devices | Healing Acceleration for Brain Aneurysm Flow Diverters | Pre-clinical |
Leadership Team at Endomimetics
JN
Joseph N. Garner, PhD
Chief Executive Officer
BB
Brigitta Brott, MD
Chief Medical Officer & Co-Founder
HJ
Ho-Wook Jun, PhD
Chief Scientific Officer & Co-Founder
JS
Jennifer Sherwood, PhD
Director, Research & Development
JC
Jun Chen, PhD
Senior Scientist